You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Claims for Patent: 9,061,052

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,061,052

Title:	Aqueous extract of tobacco leaves, its uses in the treatment of dependence
Abstract:	The invention relates to the use of an aqueous extract of tobacco leaves for the preparation of a medicament for the treatment of dependence, in particular tobacco dependence, and to a sterile injection solution and a kit which can be used for the treatment of dependence, in particular of tobacco.
Inventor(s):	Nicolas; Jean-Pierre (Ste Cecile les Vignes, FR)
Assignee:	NFL BIOSCIENCE (Paris, FR)
Application Number:	12/299,850
Patent Claims:	1. A method for treating tobacco dependence in a subject in need thereof, wherein said method comprises subcutaneously injecting into the patient in need thereof a solution containing an effective amount of an aqueous extract of tobacco leaves and sterile water, wherein said aqueous extract of tobacco leaves has a dried matter content of 0.05 to 150 mg/ml, and wherein said aqueous extract of tobacco leaves is substantially nicotine-free. 2. The method of claim 1, wherein said aqueous extract is lyophilized. 3. The method of claim 1, wherein said aqueous extract has a dry matter content of 0.5 to 100 mg of dry extract of tobacco leaves per ml of sterile water. 4. The method of claim 1, wherein said aqueous extract has a dry matter content of 1 to 20 mg of dry extract of tobacco leaves per ml of sterile water. 5. The method of claim 1, wherein said method comprises a single injection of the solution to the patient. 6. The method of claim 1, wherein said method comprises at least two injections of the solution to the patient, wherein said at least to injections are performed at time intervals of 4 to 30 days. 7. The method of claim 6, wherein the at least two injections are performed at time intervals of 5 to 15 days. 8. The method of claim 6, wherein the at least two injections are performed at time intervals of 6 to 13 days.

Details for Patent 9,061,052

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006	⤷ Try a Trial	2026-05-09
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.